The KANSL1 gene helps control when many other genes are turned on, especially during brain and body development. This gene plays an important role in helping cells read genetic instructions in an orderly way. If one copy of the KANSL1 gene does not work properly, it can cause Koolen-de Vries syndrome, a condition often linked to low muscle tone, delayed speech and movement, and mild to moderate intellectual disability. Some people also have feeding issues early in life or differences in the heart, kidneys, or facial features.
What is a gene?
Genes are sections of DNA that hold information your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the working parts of cells. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
KANSL1Gene function
What if the gene works
The KANSL1 gene helps cells switch other genes on at the right time by loosening packed DNA. This supports normal brain development and everyday cell activity.
Risk
What if the gene does not work
More disruptive variants in the KANSL1 gene often cause Koolen-de Vries syndrome, with developmental delay or intellectual disability, low muscle tone, and sometimes heart, kidney, or seizure-related features. Milder variants may lead to milder or more variable features.
Treatment
What does that mean for your treatment
No treatment or medication choice guided specifically by the KANSL1 gene is currently established. Care is supportive and usually tailored to a person’s symptoms rather than the exact KANSL1 variant. The KANSL1 gene is being studied to better understand brain development and related pathways, but this has not yet led to guideline based medicines.
Conditions associated with KANSL1
Gene function
What if the gene works
Your cells need careful control over which genes are active and when. The KANSL1 gene helps manage that timing by supporting a protein team that opens packed DNA and makes it easier to read the right instructions. Understanding how the KANSL1 gene works helps explain how cells stay organized from one task to the next.
The KANSL1 gene helps loosen how DNA is wrapped around its packaging proteins. This gives cells better access to selected instructions when they need to turn certain genes on.
Inside the NSL complex (a protein group that helps control gene activity), its protein helps place small chemical tags on histones, the proteins that package DNA. These tags support steady, well timed gene expression across many tissues.
By helping many genes switch on in an orderly way, the KANSL1 gene supports routine cell growth, maintenance, and development. This broad control matters because cells need different instructions at different times.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Most disease-causing changes in the KANSL1 gene lower the amount of working KANSL1 protein by creating a shortened, unstable protein or by stopping one copy of the gene from being used. This overview of KANSL1 gene variant effects explains why more severe loss-of-function variants usually disrupt control of other genes more than milder variants that still leave some protein activity. In KANSL1-related syndrome, that difference can influence how clearly the condition appears.
How variants are linked to conditions
Pathogenic variants in the KANSL1 gene cause Koolen-de Vries syndrome, a genetic condition linked to developmental delay, intellectual disability, low muscle tone, and a characteristic pattern of facial features. Some people also have speech and learning difficulties, seizures, or heart and kidney differences. When looking at how variants in the KANSL1 gene are linked to conditions, this is the main well-established association, including cases caused by a 17q21.31 deletion that includes KANSL1.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KANSL1, risk is mostly set by the genetic change itself rather than lifestyle or everyday exposures. Most people living with a KANSL1-related condition have it because of a new change that was not inherited, but if a parent carries a KANSL1 change, the chance of passing it on is much higher.
Inheritance of KANSL1 variants
KANSL1-related conditions such as Koolen-de Vries syndrome follow an autosomal dominant inheritance pattern, which means a child can inherit the condition if one parent carries a disease-causing variant in the KANSL1 gene. In many families, though, how KANSL1 gene variants are inherited is shaped by the fact that the variant often arises new in the child and is not passed down from either parent. When a parent does carry the variant, each pregnancy has a 50% chance of passing it on.
What does my KANSL1 result mean for my family?
For many living with a disease-causing change in the KANSL1 gene, the condition follows a dominant family pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, though, the change happened for the first time in the affected child and was not inherited from either parent. That means the family impact can differ depending on whether the change was inherited or new in that child.
Genetic information
Genetic testing
How you find out about variants
Doctors find KANSL1 variants with DNA testing from blood or saliva. KANSL1 genetic testing may include sequencing to look for small DNA changes and chromosomal microarray or deletion and duplication testing to detect a missing copy of the gene. Results can confirm a variant, but not exactly how symptoms will vary.
When should I consider getting a genetic test?
Consider KANSL1 testing when a child has ongoing developmental delay, low muscle tone, speech delay, or learning difficulties that suggest Koolen-de Vries syndrome. It may also help when there is a known KANSL1 change or a family history of this condition.
A genetic result is only one part of your health story
How much a genetic result can tell you depends on the condition and the type of variant involved, even though it can provide valuable insight. Many factors shape how the body works over time, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how quickly a drug is broken down, how strongly it acts, or how sensitive you are to side effects. This helps explain why the same treatment works well for one person, works less well for another, or feels too strong at a usual dose. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many drugs, genes influence both how strongly a medicine works and how the body processes it. This information can support more informed, more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the KANSL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so general medication concerns are best discussed with your doctor. Seek medical advice if new side effects appear after starting a treatment, if symptoms are getting worse, or if a medicine does not seem to be helping.
History
The KANSL1 gene entered medical genetics through the study of a recurrent chromosome change at 17q21.31, first linked to a recognizable pattern of developmental and physical features in affected children. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped narrow the search to KANSL1 as the main cause in many people with Koolen-de Vries syndrome. From these first observations, research expanded steadily as newer DNA testing methods could detect both larger missing pieces of chromosome and smaller variants within the KANSL1 gene itself. This clarified that different types of changes in the same gene could lead to a similar condition. Over time, descriptions became more precise, giving families a clearer name and explanation for a condition that had often gone undiagnosed.